Dare Bioscience, Inc.
Pagina dedicata companiei Dare Bioscience, Inc. listata cu simbolul US.DARE
Descriere companie[edit | ]
Dare Bioscience, Inc. (www.darebioscience.com) is a clinical-stage biopharmaceutical company. The Company is focused on advancing products for women’s health. Its portfolio of differentiated therapies expands treatment options, improve outcomes and facilitate convenience for women, primarily in the areas of contraception, vaginal health, sexual health and fertility. Its product pipeline includes three product candidates in advanced stages of clinical development, three in Phase I clinical development and three in pre-clinical stage development. The product candidates in its pipeline include DARE-BV1, Ovaprene, Sildenafil Cream, 3.6%, DARE-HRT1, DARE-FRT1, DARE-VVA1, DARE-LARC1, ORB-204 and ORB-214, and DARE-RH1. DARE-BV1 is focused on the treatment for bacterial vaginosis. Ovaprene is designed to provide multiple weeks of contraceptive protection and Sildenafil Cream, 3.6% is for the treatment of female sexual arousal disorders are under advanced stages of clinical development.
Grafic actiuni companie[edit | ]